Signature Estate & Investment Advisors LLC Has $231,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Posted by Renee Jackson on Nov 17th, 2024

Signature Estate & Investment Advisors LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,336 shares of the exchange traded fund’s stock after purchasing an additional 125 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $231,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. ORG Partners LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $40,000. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $40,000. ORG Wealth Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $44,000. Waldron Private Wealth LLC bought a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $54,000. Finally, Resources Management Corp CT ADV raised its holdings in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $91.83 on Friday. The company has a 50-day moving average price of $98.95 and a 200-day moving average price of $96.11. The stock has a market capitalization of $7.00 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $69.32 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.